InvestEgate | Company Announcements
Comprehensive and timely details of regulatory and non regulatory announcements from companies in the FTSE 250 mid cap shares index
Source: investegate.co.uk
Page 31 - Mid Caps News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mid Caps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mid Caps Today - Breaking & Trending Today
Nicox's Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell Disease
Press ReleaseNicox's Partner Fera Pharmaceuticals Obtains Orphan Drug Designation from the U.S. FDA for Naproxcinod for the Treatment of Sickle Cell DiseaseMarch 2nd, 2022 - release at 7:30 am CET Sophia
Source: finanznachrichten.de
InvestEgate | Company Announcements
Comprehensive and timely details of regulatory and non regulatory announcements from companies in the FTSE 250 mid cap shares index
Source: investegate.co.uk
InvestEgate | Company Announcements
Comprehensive and timely details of regulatory and non regulatory announcements from companies in the FTSE 250 mid cap shares index
Source: investegate.co.uk
Nicox's Partner Ocumension Obtains Positive Phase 3 Clinical Trial Results for ZERVIATE in China
Press ReleaseNicox's Partner Ocumension Obtains Positive Phase 3 Clinical Trial Results for ZERVIATE in China ZERVIATE (cetirizine ophthalmic solution), 0.24% was non-inferior to comparator
Source: finanznachrichten.de